UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Diabetes Mellitus Type 2 and Abnormal Glucose Metabolism in the Setting of Human Immunodeficiency Virus

Endocrinology and metabolism clinics of North America, 2014-09, Vol.43 (3), p.685-696

2014

Volltextzugriff (PDF)

Sofosbuvir for treatment of chronic hepatitis C

Hepatology international, 2015-04, Vol.9 (2), p.161-173

2015

Volltextzugriff (PDF)

To Eliminate Hepatitis C in People Who Inject Drugs, Stop Ignoring Drug User Health

Clinical infectious diseases, 2021-07, Vol.73 (1), p.e119-e121

2021

Volltextzugriff (PDF)

Safe and effective sofosbuvir-based therapy in patients with mental health disease on hepatitis C virus treatment

World journal of hepatology, 2016-11, Vol.8 (31), p.1318-1326

2016

Volltextzugriff (PDF)

Expanding the Evidence on Integrated Opioid Use Disorder and Infectious Disease Care

Journal of addiction medicine, 2021-11, Vol.15 (6), p.452-453

2021

Volltextzugriff (PDF)

Hepatitis C virus (HCV)-specific T cell confer resistance to HCV re-infection after sustained virologic response in a non-cytolytic fashion among people who inject drugs: results from ANCHOR study

Journal of hepatology, 2022-07, Vol.77, p.S571

2022

Volltextzugriff (PDF)

Expansion of Treatment for Hepatitis C Virus Infection by Task Shifting to Community-Based Nonspecialist Providers: A Nonrandomized Clinical Trial

Annals of internal medicine, 2017-09, Vol.167 (5), p.311

2017

Volltextzugriff (PDF)

Long-term outcomes associated with task-shifting of HCV treatment by non-specialist providers: five year follow-up from the ASCEND cohort

Journal of hepatology, 2022-07, Vol.77, p.S574

2022

Volltextzugriff (PDF)

Concurrent Initiation of Hepatitis C and Opioid Use Disorder Treatment in People Who Inject Drugs

Clinical infectious diseases, 2020-10, Vol.71 (7), p.1715-1722

2020

Volltextzugriff (PDF)

Diabetes Mellitus Type II and Abnormal Glucose Metabolism in the setting of HIV

Endocrinology and metabolism clinics of North America, 2014-09, Vol.43 (3), p.685-696

2014

Volltextzugriff (PDF)

Association of sustained virologic response with measures of direct-acting antiviral adherence in patients with Hepatitis C: data from the ASCEND and ANCHOR investigations

Journal of hepatology, 2022-07, Vol.77, p.S552

2022

Volltextzugriff (PDF)

Expansion of Treatment for Hepatitis C Virus Infection

Annals of internal medicine, 2018-03, Vol.168 (6), p.457

2018

Volltextzugriff (PDF)

Diabetes Mellitus Type 2 and Abnormal Glucose Metabolism in the Setting of Human Immunodeficiency Virus: HIV and Endocrine Disorders

Endocrinology and metabolism clinics of North America, 2014, Vol.43 (3)

2014

Volltextzugriff (PDF)

Dose‐specific clinical outcomes in patients with opioid use disorder treated with 24–32 mg/day of buprenorphine

Addiction (Abingdon, England), 2024-11, Vol.119 (11), p.1964-1972

2024

Volltextzugriff (PDF)

Dose‐specific clinical outcomes in patients with opioid use disorder treated with 24–32mg/day of buprenorphine

Addiction (Abingdon, England), 2024-11, Vol.119 (11), p.1964-1972

2024

Volltextzugriff (PDF)

No Improvement in Hemoglobin A1c Following Hepatitis C Viral Clearance in Patients With and Without HIV

The Journal of infectious diseases, 2017-12, Vol.217 (1), p.47-50

2017

Volltextzugriff (PDF)

HCV reinfection associated with IDU and cocaine use in a cohort of people with OUD: 4 Year follow-up data from the ANCHOR cohort

Journal of hepatology, 2022-07, Vol.77, p.S572

2022

Volltextzugriff (PDF)

Undertreatment of opioid use disorder in patients hospitalized with injection drug use-associated infections

AIDS (London), 2023-10, Vol.37 (12), p.1799-1809

2023

Volltextzugriff (PDF)

Clinical Laboratory Testing in the Era of Directly Acting Antiviral Therapies for Hepatitis C

Clinical microbiology reviews, 2017-01, Vol.30 (1), p.23-42

2017

Volltextzugriff (PDF)

Testosterone in Men With Chronic Hepatitis C Infection and After Hepatitis C Viral Clearance

Clinical infectious diseases, 2019-08, Vol.69 (4), p.571-576

2019

Volltextzugriff (PDF)

100. "They Never Asked Me": A Mixed-Methods Study to Evaluate the INJECT-RESPECT Tool for Assessing Infectious and Non-Infectious risks of Injection Drug Use

Open forum infectious diseases, 2023-11, Vol.10 (Supplement_2)

2023

Volltextzugriff (PDF)

Hepatitis C cure and medications for opioid use disorder improve health-related quality of life in patients with opioid use disorder actively engaged in substance use

The International journal of drug policy, 2023-01, Vol.111, p.103906-103906, Article 103906

2023

Volltextzugriff (PDF)

Four-Week Direct-Acting Antiviral Regimens in Noncirrhotic Patients With Hepatitis C Virus Genotype 1 Infection: An Open-Label, Nonrandomized Trial

Annals of internal medicine, 2015-12, Vol.163 (12), p.899-907

2015

Volltextzugriff (PDF)

Successful Retreatment of Chronic HCV Genotype-1 Infection With Ledipasvir and Sofosbuvir After Initial Short Course Therapy With Direct-Acting Antiviral Regimens

Clinical infectious diseases, 2016-02, Vol.62 (3), p.280-288

2016

Volltextzugriff (PDF)

Hepatitis C genotype 3 disease

Hepatology international, 2016-11, Vol.10 (6), p.861-870

2016

Volltextzugriff (PDF)

1 – 25 von 52

Suche als RSS-Feed

Aktive Filter

ThemaHiv

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(48)
Mit Volltextzugriff
(38)

Publikationsform

Artikel
(52)

Sprache

Englisch
(52)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Diabetes Mellitus Type 2 and Abnormal Glucose Metabolism in the Setting of Human Immunodeficiency Virus

Sofosbuvir for treatment of chronic hepatitis C

To Eliminate Hepatitis C in People Who Inject Drugs, Stop Ignoring Drug User Health

Safe and effective sofosbuvir-based therapy in patients with mental health disease on hepatitis C virus treatment

Expanding the Evidence on Integrated Opioid Use Disorder and Infectious Disease Care

Hepatitis C virus (HCV)-specific T cell confer resistance to HCV re-infection after sustained virologic response in a non-cytolytic fashion among people who inject drugs: results from ANCHOR study

Expansion of Treatment for Hepatitis C Virus Infection by Task Shifting to Community-Based Nonspecialist Providers: A Nonrandomized Clinical Trial

Long-term outcomes associated with task-shifting of HCV treatment by non-specialist providers: five year follow-up from the ASCEND cohort

Concurrent Initiation of Hepatitis C and Opioid Use Disorder Treatment in People Who Inject Drugs

Diabetes Mellitus Type II and Abnormal Glucose Metabolism in the setting of HIV

Association of sustained virologic response with measures of direct-acting antiviral adherence in patients with Hepatitis C: data from the ASCEND and ANCHOR investigations

Expansion of Treatment for Hepatitis C Virus Infection

Diabetes Mellitus Type 2 and Abnormal Glucose Metabolism in the Setting of Human Immunodeficiency Virus: HIV and Endocrine Disorders

Dose‐specific clinical outcomes in patients with opioid use disorder treated with 24–32 mg/day of buprenorphine

Dose‐specific clinical outcomes in patients with opioid use disorder treated with 24–32mg/day of buprenorphine

No Improvement in Hemoglobin A1c Following Hepatitis C Viral Clearance in Patients With and Without HIV

HCV reinfection associated with IDU and cocaine use in a cohort of people with OUD: 4 Year follow-up data from the ANCHOR cohort

Undertreatment of opioid use disorder in patients hospitalized with injection drug use-associated infections

Clinical Laboratory Testing in the Era of Directly Acting Antiviral Therapies for Hepatitis C

Testosterone in Men With Chronic Hepatitis C Infection and After Hepatitis C Viral Clearance

100. "They Never Asked Me": A Mixed-Methods Study to Evaluate the INJECT-RESPECT Tool for Assessing Infectious and Non-Infectious risks of Injection Drug Use

Hepatitis C cure and medications for opioid use disorder improve health-related quality of life in patients with opioid use disorder actively engaged in substance use

Four-Week Direct-Acting Antiviral Regimens in Noncirrhotic Patients With Hepatitis C Virus Genotype 1 Infection: An Open-Label, Nonrandomized Trial

Successful Retreatment of Chronic HCV Genotype-1 Infection With Ledipasvir and Sofosbuvir After Initial Short Course Therapy With Direct-Acting Antiviral Regimens

Hepatitis C genotype 3 disease

Aktive Filter

Suchergebnisse filtern